Company Search:
Advanced Search
Sponsored Links
Peptron Inc Company Snapshot
Peptron Inc operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Peptron Inc with three other pharmaceutical manufacturers in Asia: Helixmith Co Ltd (2018 sales of 5.28 billion Korean Won [US$4.53 million] of which 60% was Drug Medicine Research and Development), Solasia Pharma KK of Japan (318.00 million Japanese Yen [US$2.92 million] of which 100% was Pharmaceutical busi), and Innovent Biologics Inc which is based in Hong Kong (11.22 million Hong Kong Dollars [US$1.43 million] of which 100% was Biopharmaceutical).

Sales Analysis. During the year ended December of 2018, sales at Peptron Inc were 3.86 billion Korean Won (US$3.31 million). This is an increase of 20.1% versus 2017, when the company's sales were 3.22 billion Korean Won. This was the fourth straight year of sales growth at Peptron Inc.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Peptron Inc
  Stock Performance Chart for Peptron Inc
  Stock Data: Recent Stock Performance:
  Current Price (11/8/2019): 15,300
(Figures in Korean Won)
1 Week 12.1%   13 Weeks 21.4%  
4 Weeks 26.4%   52 Weeks -34.5%  
Peptron Inc Key Data:
  Ticker: 087010 Country: Korea (South)
  Exchanges: SEO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2018 Sales 3,861,733,210
(Year Ending Jan 2019).
Employees: 64
  Currency: Korean Won Market Cap: 234,495,450,000
  Fiscal Yr Ends: December Shares Outstanding: 15,326,500
  Share Type: Common Closely Held Shares: 1,654,536
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.